NFKB1 and metabolic dysfunction-associated steatotic liver disease: THRs influence the NF-κB pathway by interacting with the IKK complex, reducing the activation of NF-κB and the downstream expression of inflammatory cytokines, which are elevated in liver diseases like MASLD and MASH [159].